Product Information
PROPAFENONE HCL ER 325 MG CAP is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.5300 per EA under NDC 16571073706. Its NADAC has been published 264 times since Aug 4, 2021.
FDA first approved this application on Jul 2, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
325 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571073706
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205956FDA Approved
7/2/2018
TE Code
AB
On Market Since
12/16/2020
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL ER 325 MG CAP has been published 264 times since Aug 4, 2021, and over the history we have for it it has declined 64.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5300 per EA |
|---|---|
| All-time high | $2.8137 (May 11, 2022) |
| All-time low | $0.4264 (Feb 18, 2026) |
| 52-week high | $0.7614 |
| 52-week low | $0.4264 |
| Median price | $0.9501 |
| Average price | $1.0769 |
| Largest weekly change | +97.6% (Oct 20, 2021) |
| Weeks tracked | 264 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PROPAFENONE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL ER 325 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL ER 325 MG CAP, manufactured by Rising Pharma Holdings Inc., is $0.5300 per EA (NDC 16571073706), effective Aug 19, 2026.
How has the price of PROPAFENONE HCL ER 325 MG CAP changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL ER 325 MG CAP has declined 64.9%. It has been tracked across 264 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL ER 325 MG CAP?
Since Aug 4, 2021, the NADAC for PROPAFENONE HCL ER 325 MG CAP has ranged from a low of $0.4264 (Feb 18, 2026) to a high of $2.8137 (May 11, 2022), with a median of $0.9501 per EA.
Are there cheaper alternatives to PROPAFENONE HCL ER 325 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of PROPAFENONE HCL ER 325 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROPAFENONE HCL ER 325 MG CAP?
PROPAFENONE HCL ER 325 MG CAP (NDC 16571073706) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.